NSETrading Window23 Jun 2026 · 23 Jun 2026, 12:11 pm
Trading Window
Tatva Chintan Pharma Chem Limited · TATVA
✦ AI Summary
Tatva Chintan Pharma Chem Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure, effective from July 1, 2026, will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This action is a standard compliance measure under SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading before financial disclosures. Such intimations are routine regulatory filings.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
TATVA_23062026121112_T.pdf
View document text
Date: 23 June 2026 Ref. No.: TCPCL/SEC/2026-27/00016
The General Manager, The Manager,
Corporate relationship department, Listing department,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Fort, Bandra-Kurla Complex, Bandra(E),
Mumbai-400 001 Mumbai-400 051
Scrip Code: 543321 Scrip Symbol: TATVA
Subject: Intimation of Closure of Trading Window
Dear Sir/Madam,
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as
amended and Company's code on prohibition of insider trading, the “Trading Window” for
dealing in the securities of the Company shall remain closed for all Designated Persons and
their immediate relatives from Wednesday, 01 July 2026 till the completion of 48 hours
after the declaration of the Unaudited Financial Results of the Company for the quarter
ending 30 June 2026.
Accordingly, all Designated Persons and their immediate relatives of the Company have
been advised not to trade in the securities of the Company during the aforesaid period of
Closure of Trading Window.
Kindly take the above information on your record.
Thanking you,
Yours faithfully,
For Tatva Chintan Pharma Chem Limited
Ishwar Nayi
Company Secretary and Compliance Officer
M. No.: A37444